SSelectStock
Sign in

RPGLIFERPG Life Sciences Limited

Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)

3,017.10
5.50%
79Strong

Price & Volume

Loading chart…

Key Ratios

Market Cap (₹ cr)4,532.00
P/E39.30
P/B7.49
PEG
ROE %20.28
ROCE %20.30
Debt / Equity0.03
EPS69.73
Revenue Growth %23.60
Profit Growth %-74.50
Dividend Yield %0.81
Promoter Holding %75.30
FII Holding %5.55
DII Holding %
Beta-0.21

“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.

Active Pattern Signals

52-Week High BreakoutLONG82%3,017.102,822.903,405.502.00
Bull FlagLONG78%3,017.102,722.503,566.901.87
Breakout with VolumeLONG75%3,017.102,822.903,405.502.00
BUYConviction 86%

Why buy

  • Revenue growth: 23.6% YoY
  • ROE: 20.3%
  • ROCE: 20.3%
  • RSI: 75
  • MACD: bullish
  • Price vs EMA21: above
  • Breakout with Volume signal (setup quality 75%)
  • Bull Flag signal (setup quality 78%)
  • 52-Week High Breakout signal (setup quality 82%)

Bull case

  • Revenue growth: 23.6% YoY
  • ROE: 20.3%
  • ROCE: 20.3%
  • RSI: 75

Bear case

  • Profit growth: -74.5% YoY
  • Max drawdown (1y): 34%
  • Beta: -0.21

Key risks

  • Profit growth: -74.5% YoY
  • Max drawdown (1y): 34%

Algorithmic analysis for research only — not SEBI-registered investment advice.

Trade Plan

Entry (CMP)
₹3,017.10
Stop Loss
₹2,685.62
risk 11%
Target 1 (1.5R)
₹3,514.32
+16.5%
Target 2 (3R)
₹4,011.54
+33.0%
Support (20d)
₹2,178.47
Resistance (52w)
₹3,063.60
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹331.48/share
ATR (volatility)
₹132.59
avg daily range

Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹132.59). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.

Score Breakdown

Fundamental
74
Technical
84
Momentum
96
Risk (safety)
48

Peers — Pharma

PGHL 0.78%
84
AJANTPHARM 1.45%
82
HESTERBIO 3.09%
81
LUPIN 1.44%
80
SUNPHARMA 1.23%
80
CORONA 0.78%
79

About

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology and pediatrics, cardiovascular, pediatrics, neurology, anti-dengue, dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.